Found: 6
Select item for more details and to access through your institution.
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2015, v. 2, n. 1, p. 1, doi. 10.1186/s40697-015-0066-5
- By:
- Publication type:
- Article
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2015, v. 2, p. 1, doi. 10.1186/s40697-015-0066-5
- By:
- Publication type:
- Article
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.
- Published in:
- Kidney International, 2014, v. 85, n. 1, p. 23, doi. 10.1038/ki.2013.391
- By:
- Publication type:
- Article
REPRESENTATIVENESS OF HONEYPOT TRIAL PARTICIPANTS TO AUSTRALASIAN PD PATIENTS.
- Published in:
- Peritoneal Dialysis International, 2017, v. 37, n. 5, p. 516, doi. 10.3747/pdi.2016.00065
- By:
- Publication type:
- Article
THE EFFECT OF EXIT-SITE ANTIBACTERIAL HONEY VERSUS NASAL MUPIROCIN PROPHYLAXIS ON THE MICROBIOLOGY AND OUTCOMES OF PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS AND EXIT-SITE INFECTIONS: A SUB-STUDY OF THE HONEYPOT TRIAL.
- Published in:
- Peritoneal Dialysis International, 2015, v. 35, n. 7, p. 712, doi. 10.3747/pdi.2014.00206
- By:
- Publication type:
- Article
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
- Published in:
- Nephrology, 2017, v. 22, n. 7, p. 548, doi. 10.1111/nep.12815
- By:
- Publication type:
- Article